nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2C8—Mometasone—systemic scleroderma	0.118	0.221	CbGbCtD
Nicardipine—ABCB1—Lisinopril—systemic scleroderma	0.0538	0.101	CbGbCtD
Nicardipine—CYP2C9—Leflunomide—systemic scleroderma	0.0529	0.0991	CbGbCtD
Nicardipine—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0487	0.0913	CbGbCtD
Nicardipine—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0469	0.0878	CbGbCtD
Nicardipine—ABCB1—Captopril—systemic scleroderma	0.0403	0.0755	CbGbCtD
Nicardipine—CYP2D6—Captopril—systemic scleroderma	0.038	0.0711	CbGbCtD
Nicardipine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0317	0.0594	CbGbCtD
Nicardipine—CYP2C19—Prednisone—systemic scleroderma	0.0314	0.0589	CbGbCtD
Nicardipine—ABCB1—Prednisone—systemic scleroderma	0.0254	0.0475	CbGbCtD
Nicardipine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.019	0.0356	CbGbCtD
Nicardipine—CYP2C9—cardial valve—systemic scleroderma	0.0154	0.184	CbGeAlD
Nicardipine—CYP3A4—Prednisone—systemic scleroderma	0.0152	0.0285	CbGbCtD
Nicardipine—ABCB1—Methotrexate—systemic scleroderma	0.0127	0.0238	CbGbCtD
Nicardipine—CALM2—artery—systemic scleroderma	0.00313	0.0374	CbGeAlD
Nicardipine—CALM1—artery—systemic scleroderma	0.00312	0.0373	CbGeAlD
Nicardipine—PDE1A—smooth muscle tissue—systemic scleroderma	0.00293	0.035	CbGeAlD
Nicardipine—CALM2—endothelium—systemic scleroderma	0.00265	0.0316	CbGeAlD
Nicardipine—CALM1—endothelium—systemic scleroderma	0.00263	0.0315	CbGeAlD
Nicardipine—CALM2—blood vessel—systemic scleroderma	0.00244	0.0292	CbGeAlD
Nicardipine—CALM1—blood vessel—systemic scleroderma	0.00243	0.029	CbGeAlD
Nicardipine—PDE1A—tendon—systemic scleroderma	0.0022	0.0263	CbGeAlD
Nicardipine—CHRM5—skin of body—systemic scleroderma	0.00206	0.0247	CbGeAlD
Nicardipine—PDE1A—lung—systemic scleroderma	0.00193	0.0231	CbGeAlD
Nicardipine—CACNA1C—connective tissue—systemic scleroderma	0.0019	0.0227	CbGeAlD
Nicardipine—CACNA1C—smooth muscle tissue—systemic scleroderma	0.00174	0.0208	CbGeAlD
Nicardipine—CACNB2—digestive system—systemic scleroderma	0.0017	0.0204	CbGeAlD
Nicardipine—CACNB2—tendon—systemic scleroderma	0.00162	0.0194	CbGeAlD
Nicardipine—CACNA2D1—tendon—systemic scleroderma	0.00152	0.0182	CbGeAlD
Nicardipine—CALM3—smooth muscle tissue—systemic scleroderma	0.00146	0.0174	CbGeAlD
Nicardipine—CACNB2—lung—systemic scleroderma	0.00142	0.017	CbGeAlD
Nicardipine—CACNA1C—digestive system—systemic scleroderma	0.00137	0.0164	CbGeAlD
Nicardipine—CACNA2D1—lung—systemic scleroderma	0.00134	0.016	CbGeAlD
Nicardipine—CALM2—connective tissue—systemic scleroderma	0.00125	0.015	CbGeAlD
Nicardipine—CALM1—connective tissue—systemic scleroderma	0.00125	0.0149	CbGeAlD
Nicardipine—CACNA1D—lung—systemic scleroderma	0.00124	0.0149	CbGeAlD
Nicardipine—CHRM3—smooth muscle tissue—systemic scleroderma	0.00117	0.014	CbGeAlD
Nicardipine—CACNA1C—lung—systemic scleroderma	0.00115	0.0137	CbGeAlD
Nicardipine—CALM2—smooth muscle tissue—systemic scleroderma	0.00114	0.0137	CbGeAlD
Nicardipine—CALM1—smooth muscle tissue—systemic scleroderma	0.00114	0.0136	CbGeAlD
Nicardipine—CALM2—skin of body—systemic scleroderma	0.00113	0.0135	CbGeAlD
Nicardipine—CALM1—skin of body—systemic scleroderma	0.00112	0.0134	CbGeAlD
Nicardipine—CALM3—tendon—systemic scleroderma	0.0011	0.0131	CbGeAlD
Nicardipine—ABCB1—blood vessel—systemic scleroderma	0.00097	0.0116	CbGeAlD
Nicardipine—CALM3—lung—systemic scleroderma	0.000961	0.0115	CbGeAlD
Nicardipine—CHRM3—digestive system—systemic scleroderma	0.000923	0.011	CbGeAlD
Nicardipine—CALM2—digestive system—systemic scleroderma	0.000904	0.0108	CbGeAlD
Nicardipine—CALM1—digestive system—systemic scleroderma	0.0009	0.0108	CbGeAlD
Nicardipine—CHRM1—lung—systemic scleroderma	0.000862	0.0103	CbGeAlD
Nicardipine—CALM2—tendon—systemic scleroderma	0.00086	0.0103	CbGeAlD
Nicardipine—CYP2C19—digestive system—systemic scleroderma	0.000858	0.0103	CbGeAlD
Nicardipine—CALM1—tendon—systemic scleroderma	0.000856	0.0102	CbGeAlD
Nicardipine—CYP2B6—skin of body—systemic scleroderma	0.00084	0.01	CbGeAlD
Nicardipine—CALM2—lung—systemic scleroderma	0.000755	0.00902	CbGeAlD
Nicardipine—CALM1—lung—systemic scleroderma	0.000751	0.00898	CbGeAlD
Nicardipine—CYP3A5—digestive system—systemic scleroderma	0.000676	0.00808	CbGeAlD
Nicardipine—CYP2B6—digestive system—systemic scleroderma	0.000672	0.00803	CbGeAlD
Nicardipine—CYP2C9—digestive system—systemic scleroderma	0.000665	0.00795	CbGeAlD
Nicardipine—CYP2E1—digestive system—systemic scleroderma	0.000631	0.00754	CbGeAlD
Nicardipine—CYP2E1—tendon—systemic scleroderma	0.0006	0.00717	CbGeAlD
Nicardipine—CYP3A5—lung—systemic scleroderma	0.000565	0.00675	CbGeAlD
Nicardipine—CYP2B6—lung—systemic scleroderma	0.000561	0.00671	CbGeAlD
Nicardipine—CYP2E1—lung—systemic scleroderma	0.000527	0.00629	CbGeAlD
Nicardipine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000522	0.00159	CcSEcCtD
Nicardipine—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000521	0.00159	CcSEcCtD
Nicardipine—Tachycardia—Leflunomide—systemic scleroderma	0.00052	0.00159	CcSEcCtD
Nicardipine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000519	0.00158	CcSEcCtD
Nicardipine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000515	0.00157	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000514	0.00157	CcSEcCtD
Nicardipine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000513	0.00156	CcSEcCtD
Nicardipine—Body temperature increased—Captopril—systemic scleroderma	0.000511	0.00156	CcSEcCtD
Nicardipine—Abdominal pain—Captopril—systemic scleroderma	0.000511	0.00156	CcSEcCtD
Nicardipine—Oedema—Mycophenolic acid—systemic scleroderma	0.000508	0.00155	CcSEcCtD
Nicardipine—CYP3A4—digestive system—systemic scleroderma	0.000507	0.00606	CbGeAlD
Nicardipine—Nausea—Pentoxifylline—systemic scleroderma	0.000507	0.00154	CcSEcCtD
Nicardipine—Malaise—Lisinopril—systemic scleroderma	0.000506	0.00154	CcSEcCtD
Nicardipine—Infection—Mycophenolic acid—systemic scleroderma	0.000505	0.00154	CcSEcCtD
Nicardipine—Vertigo—Lisinopril—systemic scleroderma	0.000504	0.00154	CcSEcCtD
Nicardipine—Diarrhoea—Mometasone—systemic scleroderma	0.000504	0.00154	CcSEcCtD
Nicardipine—Hypokalaemia—Prednisone—systemic scleroderma	0.000504	0.00153	CcSEcCtD
Nicardipine—Syncope—Lisinopril—systemic scleroderma	0.000503	0.00153	CcSEcCtD
Nicardipine—Shock—Mycophenolic acid—systemic scleroderma	0.0005	0.00152	CcSEcCtD
Nicardipine—CYP2D6—digestive system—systemic scleroderma	0.000499	0.00597	CbGeAlD
Nicardipine—Hypotension—Leflunomide—systemic scleroderma	0.000498	0.00152	CcSEcCtD
Nicardipine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000498	0.00152	CcSEcCtD
Nicardipine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000496	0.00151	CcSEcCtD
Nicardipine—Palpitations—Lisinopril—systemic scleroderma	0.000496	0.00151	CcSEcCtD
Nicardipine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000493	0.0015	CcSEcCtD
Nicardipine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000492	0.0015	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000486	0.00148	CcSEcCtD
Nicardipine—Tension—Mycophenolate mofetil—systemic scleroderma	0.000483	0.00147	CcSEcCtD
Nicardipine—Insomnia—Leflunomide—systemic scleroderma	0.000482	0.00147	CcSEcCtD
Nicardipine—Paraesthesia—Leflunomide—systemic scleroderma	0.000479	0.00146	CcSEcCtD
Nicardipine—Myalgia—Lisinopril—systemic scleroderma	0.000478	0.00146	CcSEcCtD
Nicardipine—Arthralgia—Lisinopril—systemic scleroderma	0.000478	0.00146	CcSEcCtD
Nicardipine—Chest pain—Lisinopril—systemic scleroderma	0.000478	0.00146	CcSEcCtD
Nicardipine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000478	0.00146	CcSEcCtD
Nicardipine—Anxiety—Lisinopril—systemic scleroderma	0.000476	0.00145	CcSEcCtD
Nicardipine—Dyspnoea—Leflunomide—systemic scleroderma	0.000475	0.00145	CcSEcCtD
Nicardipine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000475	0.00145	CcSEcCtD
Nicardipine—Discomfort—Lisinopril—systemic scleroderma	0.000472	0.00144	CcSEcCtD
Nicardipine—Dyspepsia—Leflunomide—systemic scleroderma	0.000469	0.00143	CcSEcCtD
Nicardipine—Vomiting—Mometasone—systemic scleroderma	0.000468	0.00143	CcSEcCtD
Nicardipine—Dry mouth—Lisinopril—systemic scleroderma	0.000467	0.00142	CcSEcCtD
Nicardipine—Sweating increased—Prednisone—systemic scleroderma	0.000466	0.00142	CcSEcCtD
Nicardipine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000465	0.00142	CcSEcCtD
Nicardipine—Rash—Mometasone—systemic scleroderma	0.000464	0.00141	CcSEcCtD
Nicardipine—Asthenia—Captopril—systemic scleroderma	0.000464	0.00141	CcSEcCtD
Nicardipine—Dermatitis—Mometasone—systemic scleroderma	0.000464	0.00141	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000463	0.00141	CcSEcCtD
Nicardipine—Confusional state—Lisinopril—systemic scleroderma	0.000462	0.00141	CcSEcCtD
Nicardipine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000462	0.00141	CcSEcCtD
Nicardipine—Headache—Mometasone—systemic scleroderma	0.000461	0.00141	CcSEcCtD
Nicardipine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000461	0.0014	CcSEcCtD
Nicardipine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00046	0.0014	CcSEcCtD
Nicardipine—Oedema—Lisinopril—systemic scleroderma	0.000458	0.0014	CcSEcCtD
Nicardipine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000457	0.00139	CcSEcCtD
Nicardipine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000456	0.00139	CcSEcCtD
Nicardipine—Constipation—Leflunomide—systemic scleroderma	0.000456	0.00139	CcSEcCtD
Nicardipine—Pain—Leflunomide—systemic scleroderma	0.000456	0.00139	CcSEcCtD
Nicardipine—Infection—Lisinopril—systemic scleroderma	0.000455	0.00139	CcSEcCtD
Nicardipine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000453	0.00138	CcSEcCtD
Nicardipine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000452	0.00138	CcSEcCtD
Nicardipine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000452	0.00138	CcSEcCtD
Nicardipine—Shock—Lisinopril—systemic scleroderma	0.000451	0.00137	CcSEcCtD
Nicardipine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000448	0.00137	CcSEcCtD
Nicardipine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000448	0.00136	CcSEcCtD
Nicardipine—Tachycardia—Lisinopril—systemic scleroderma	0.000447	0.00136	CcSEcCtD
Nicardipine—Abdominal pain—Azathioprine—systemic scleroderma	0.000446	0.00136	CcSEcCtD
Nicardipine—Body temperature increased—Azathioprine—systemic scleroderma	0.000446	0.00136	CcSEcCtD
Nicardipine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000443	0.00135	CcSEcCtD
Nicardipine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000443	0.00135	CcSEcCtD
Nicardipine—Diarrhoea—Captopril—systemic scleroderma	0.000443	0.00135	CcSEcCtD
Nicardipine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000442	0.00135	CcSEcCtD
Nicardipine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000441	0.00134	CcSEcCtD
Nicardipine—Erectile dysfunction—Prednisone—systemic scleroderma	0.000441	0.00134	CcSEcCtD
Nicardipine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000439	0.00134	CcSEcCtD
Nicardipine—Nausea—Mometasone—systemic scleroderma	0.000437	0.00133	CcSEcCtD
Nicardipine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000436	0.00133	CcSEcCtD
Nicardipine—Constipation—Mycophenolic acid—systemic scleroderma	0.000435	0.00132	CcSEcCtD
Nicardipine—Pain—Mycophenolic acid—systemic scleroderma	0.000435	0.00132	CcSEcCtD
Nicardipine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000435	0.00132	CcSEcCtD
Nicardipine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000432	0.00132	CcSEcCtD
Nicardipine—Hypotension—Lisinopril—systemic scleroderma	0.000428	0.0013	CcSEcCtD
Nicardipine—Dizziness—Captopril—systemic scleroderma	0.000428	0.0013	CcSEcCtD
Nicardipine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000425	0.00129	CcSEcCtD
Nicardipine—Body temperature increased—Leflunomide—systemic scleroderma	0.000421	0.00128	CcSEcCtD
Nicardipine—Abdominal pain—Leflunomide—systemic scleroderma	0.000421	0.00128	CcSEcCtD
Nicardipine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00042	0.00128	CcSEcCtD
Nicardipine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000419	0.00128	CcSEcCtD
Nicardipine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000419	0.00128	CcSEcCtD
Nicardipine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000419	0.00128	CcSEcCtD
Nicardipine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000419	0.00128	CcSEcCtD
Nicardipine—Myocardial infarction—Prednisone—systemic scleroderma	0.000418	0.00127	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000417	0.00127	CcSEcCtD
Nicardipine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000417	0.00127	CcSEcCtD
Nicardipine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000416	0.00127	CcSEcCtD
Nicardipine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000416	0.00127	CcSEcCtD
Nicardipine—Insomnia—Lisinopril—systemic scleroderma	0.000414	0.00126	CcSEcCtD
Nicardipine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000414	0.00126	CcSEcCtD
Nicardipine—Paraesthesia—Lisinopril—systemic scleroderma	0.000411	0.00125	CcSEcCtD
Nicardipine—Vomiting—Captopril—systemic scleroderma	0.000411	0.00125	CcSEcCtD
Nicardipine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000409	0.00125	CcSEcCtD
Nicardipine—Dyspnoea—Lisinopril—systemic scleroderma	0.000408	0.00124	CcSEcCtD
Nicardipine—Rash—Captopril—systemic scleroderma	0.000408	0.00124	CcSEcCtD
Nicardipine—Dermatitis—Captopril—systemic scleroderma	0.000407	0.00124	CcSEcCtD
Nicardipine—Somnolence—Lisinopril—systemic scleroderma	0.000407	0.00124	CcSEcCtD
Nicardipine—Headache—Captopril—systemic scleroderma	0.000405	0.00123	CcSEcCtD
Nicardipine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000405	0.00123	CcSEcCtD
Nicardipine—Dyspepsia—Lisinopril—systemic scleroderma	0.000403	0.00123	CcSEcCtD
Nicardipine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000402	0.00122	CcSEcCtD
Nicardipine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000402	0.00122	CcSEcCtD
Nicardipine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000401	0.00122	CcSEcCtD
Nicardipine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000399	0.00121	CcSEcCtD
Nicardipine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000395	0.0012	CcSEcCtD
Nicardipine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000393	0.0012	CcSEcCtD
Nicardipine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000393	0.0012	CcSEcCtD
Nicardipine—Pain—Lisinopril—systemic scleroderma	0.000392	0.00119	CcSEcCtD
Nicardipine—Constipation—Lisinopril—systemic scleroderma	0.000392	0.00119	CcSEcCtD
Nicardipine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000392	0.00119	CcSEcCtD
Nicardipine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000388	0.00118	CcSEcCtD
Nicardipine—Diarrhoea—Azathioprine—systemic scleroderma	0.000386	0.00118	CcSEcCtD
Nicardipine—Nausea—Captopril—systemic scleroderma	0.000384	0.00117	CcSEcCtD
Nicardipine—Asthenia—Leflunomide—systemic scleroderma	0.000382	0.00117	CcSEcCtD
Nicardipine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000377	0.00115	CcSEcCtD
Nicardipine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000375	0.00114	CcSEcCtD
Nicardipine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000375	0.00114	CcSEcCtD
Nicardipine—Dizziness—Azathioprine—systemic scleroderma	0.000373	0.00114	CcSEcCtD
Nicardipine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000368	0.00112	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000366	0.00111	CcSEcCtD
Nicardipine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000365	0.00111	CcSEcCtD
Nicardipine—Diarrhoea—Leflunomide—systemic scleroderma	0.000365	0.00111	CcSEcCtD
Nicardipine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000363	0.00111	CcSEcCtD
Nicardipine—Abdominal pain—Lisinopril—systemic scleroderma	0.000362	0.0011	CcSEcCtD
Nicardipine—Body temperature increased—Lisinopril—systemic scleroderma	0.000362	0.0011	CcSEcCtD
Nicardipine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00036	0.0011	CcSEcCtD
Nicardipine—ABCB1—digestive system—systemic scleroderma	0.000359	0.00429	CbGeAlD
Nicardipine—Vomiting—Azathioprine—systemic scleroderma	0.000359	0.00109	CcSEcCtD
Nicardipine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000358	0.00109	CcSEcCtD
Nicardipine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000357	0.00109	CcSEcCtD
Nicardipine—Rash—Azathioprine—systemic scleroderma	0.000356	0.00108	CcSEcCtD
Nicardipine—Dermatitis—Azathioprine—systemic scleroderma	0.000356	0.00108	CcSEcCtD
Nicardipine—Flushing—Prednisone—systemic scleroderma	0.000355	0.00108	CcSEcCtD
Nicardipine—Headache—Azathioprine—systemic scleroderma	0.000354	0.00108	CcSEcCtD
Nicardipine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000353	0.00108	CcSEcCtD
Nicardipine—Dizziness—Leflunomide—systemic scleroderma	0.000352	0.00107	CcSEcCtD
Nicardipine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000348	0.00106	CcSEcCtD
Nicardipine—Conjunctivitis—Methotrexate—systemic scleroderma	0.000346	0.00106	CcSEcCtD
Nicardipine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000343	0.00105	CcSEcCtD
Nicardipine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000343	0.00105	CcSEcCtD
Nicardipine—Sweating—Methotrexate—systemic scleroderma	0.000342	0.00104	CcSEcCtD
Nicardipine—Haematuria—Methotrexate—systemic scleroderma	0.00034	0.00104	CcSEcCtD
Nicardipine—Vomiting—Leflunomide—systemic scleroderma	0.000339	0.00103	CcSEcCtD
Nicardipine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000337	0.00103	CcSEcCtD
Nicardipine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000336	0.00102	CcSEcCtD
Nicardipine—Rash—Leflunomide—systemic scleroderma	0.000336	0.00102	CcSEcCtD
Nicardipine—Dermatitis—Leflunomide—systemic scleroderma	0.000336	0.00102	CcSEcCtD
Nicardipine—Nausea—Azathioprine—systemic scleroderma	0.000335	0.00102	CcSEcCtD
Nicardipine—Headache—Leflunomide—systemic scleroderma	0.000334	0.00102	CcSEcCtD
Nicardipine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000331	0.00101	CcSEcCtD
Nicardipine—Asthenia—Lisinopril—systemic scleroderma	0.000329	0.001	CcSEcCtD
Nicardipine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000328	0.001	CcSEcCtD
Nicardipine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000323	0.000985	CcSEcCtD
Nicardipine—Rash—Mycophenolic acid—systemic scleroderma	0.000321	0.000977	CcSEcCtD
Nicardipine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00032	0.000976	CcSEcCtD
Nicardipine—Headache—Mycophenolic acid—systemic scleroderma	0.000319	0.000971	CcSEcCtD
Nicardipine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000317	0.000967	CcSEcCtD
Nicardipine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000317	0.000967	CcSEcCtD
Nicardipine—Nausea—Leflunomide—systemic scleroderma	0.000317	0.000965	CcSEcCtD
Nicardipine—Vision blurred—Prednisone—systemic scleroderma	0.000314	0.000957	CcSEcCtD
Nicardipine—Diarrhoea—Lisinopril—systemic scleroderma	0.000313	0.000955	CcSEcCtD
Nicardipine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000309	0.000942	CcSEcCtD
Nicardipine—Visual impairment—Methotrexate—systemic scleroderma	0.000308	0.00094	CcSEcCtD
Nicardipine—Agitation—Prednisone—systemic scleroderma	0.000306	0.000933	CcSEcCtD
Nicardipine—Dizziness—Lisinopril—systemic scleroderma	0.000303	0.000923	CcSEcCtD
Nicardipine—Nausea—Mycophenolic acid—systemic scleroderma	0.000302	0.00092	CcSEcCtD
Nicardipine—Malaise—Prednisone—systemic scleroderma	0.000301	0.000916	CcSEcCtD
Nicardipine—ABCB1—lung—systemic scleroderma	0.0003	0.00359	CbGeAlD
Nicardipine—Vertigo—Prednisone—systemic scleroderma	0.000299	0.000912	CcSEcCtD
Nicardipine—Syncope—Prednisone—systemic scleroderma	0.000299	0.000911	CcSEcCtD
Nicardipine—Tinnitus—Methotrexate—systemic scleroderma	0.000298	0.000909	CcSEcCtD
Nicardipine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000296	0.000901	CcSEcCtD
Nicardipine—Loss of consciousness—Prednisone—systemic scleroderma	0.000293	0.000893	CcSEcCtD
Nicardipine—Vomiting—Lisinopril—systemic scleroderma	0.000291	0.000887	CcSEcCtD
Nicardipine—Rash—Lisinopril—systemic scleroderma	0.000289	0.00088	CcSEcCtD
Nicardipine—Dermatitis—Lisinopril—systemic scleroderma	0.000289	0.000879	CcSEcCtD
Nicardipine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000288	0.000877	CcSEcCtD
Nicardipine—Hypertension—Prednisone—systemic scleroderma	0.000288	0.000877	CcSEcCtD
Nicardipine—Headache—Lisinopril—systemic scleroderma	0.000287	0.000874	CcSEcCtD
Nicardipine—Myalgia—Prednisone—systemic scleroderma	0.000284	0.000865	CcSEcCtD
Nicardipine—Arthralgia—Prednisone—systemic scleroderma	0.000284	0.000865	CcSEcCtD
Nicardipine—Anxiety—Prednisone—systemic scleroderma	0.000283	0.000862	CcSEcCtD
Nicardipine—Discomfort—Prednisone—systemic scleroderma	0.00028	0.000854	CcSEcCtD
Nicardipine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000275	0.000837	CcSEcCtD
Nicardipine—Nausea—Lisinopril—systemic scleroderma	0.000272	0.000829	CcSEcCtD
Nicardipine—Oedema—Prednisone—systemic scleroderma	0.000272	0.000829	CcSEcCtD
Nicardipine—Infection—Prednisone—systemic scleroderma	0.00027	0.000823	CcSEcCtD
Nicardipine—Shock—Prednisone—systemic scleroderma	0.000268	0.000815	CcSEcCtD
Nicardipine—Tachycardia—Prednisone—systemic scleroderma	0.000265	0.000809	CcSEcCtD
Nicardipine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000809	CcSEcCtD
Nicardipine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000263	0.000801	CcSEcCtD
Nicardipine—Vision blurred—Methotrexate—systemic scleroderma	0.000263	0.0008	CcSEcCtD
Nicardipine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000258	0.000788	CcSEcCtD
Nicardipine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000255	0.000777	CcSEcCtD
Nicardipine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000253	0.000771	CcSEcCtD
Nicardipine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000253	0.00077	CcSEcCtD
Nicardipine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000766	CcSEcCtD
Nicardipine—Malaise—Methotrexate—systemic scleroderma	0.000251	0.000765	CcSEcCtD
Nicardipine—Vertigo—Methotrexate—systemic scleroderma	0.00025	0.000763	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000248	0.000755	CcSEcCtD
Nicardipine—Insomnia—Prednisone—systemic scleroderma	0.000246	0.00075	CcSEcCtD
Nicardipine—Paraesthesia—Prednisone—systemic scleroderma	0.000244	0.000744	CcSEcCtD
Nicardipine—Dyspepsia—Prednisone—systemic scleroderma	0.000239	0.00073	CcSEcCtD
Nicardipine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000238	0.000726	CcSEcCtD
Nicardipine—Arthralgia—Methotrexate—systemic scleroderma	0.000237	0.000723	CcSEcCtD
Nicardipine—Chest pain—Methotrexate—systemic scleroderma	0.000237	0.000723	CcSEcCtD
Nicardipine—Myalgia—Methotrexate—systemic scleroderma	0.000237	0.000723	CcSEcCtD
Nicardipine—Discomfort—Methotrexate—systemic scleroderma	0.000234	0.000714	CcSEcCtD
Nicardipine—Constipation—Prednisone—systemic scleroderma	0.000233	0.000709	CcSEcCtD
Nicardipine—Confusional state—Methotrexate—systemic scleroderma	0.000229	0.000698	CcSEcCtD
Nicardipine—Infection—Methotrexate—systemic scleroderma	0.000226	0.000688	CcSEcCtD
Nicardipine—Feeling abnormal—Prednisone—systemic scleroderma	0.000224	0.000683	CcSEcCtD
Nicardipine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000223	0.000678	CcSEcCtD
Nicardipine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000222	0.000678	CcSEcCtD
Nicardipine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00022	0.00067	CcSEcCtD
Nicardipine—Abdominal pain—Prednisone—systemic scleroderma	0.000215	0.000655	CcSEcCtD
Nicardipine—Body temperature increased—Prednisone—systemic scleroderma	0.000215	0.000655	CcSEcCtD
Nicardipine—Hypotension—Methotrexate—systemic scleroderma	0.000212	0.000647	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000207	0.000631	CcSEcCtD
Nicardipine—Insomnia—Methotrexate—systemic scleroderma	0.000206	0.000627	CcSEcCtD
Nicardipine—Paraesthesia—Methotrexate—systemic scleroderma	0.000204	0.000622	CcSEcCtD
Nicardipine—Dyspnoea—Methotrexate—systemic scleroderma	0.000203	0.000618	CcSEcCtD
Nicardipine—Somnolence—Methotrexate—systemic scleroderma	0.000202	0.000616	CcSEcCtD
Nicardipine—Hypersensitivity—Prednisone—systemic scleroderma	0.0002	0.000611	CcSEcCtD
Nicardipine—Dyspepsia—Methotrexate—systemic scleroderma	0.0002	0.00061	CcSEcCtD
Nicardipine—Asthenia—Prednisone—systemic scleroderma	0.000195	0.000595	CcSEcCtD
Nicardipine—Pain—Methotrexate—systemic scleroderma	0.000194	0.000592	CcSEcCtD
Nicardipine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000187	0.000571	CcSEcCtD
Nicardipine—Diarrhoea—Prednisone—systemic scleroderma	0.000186	0.000567	CcSEcCtD
Nicardipine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000186	0.000566	CcSEcCtD
Nicardipine—Dizziness—Prednisone—systemic scleroderma	0.00018	0.000548	CcSEcCtD
Nicardipine—Abdominal pain—Methotrexate—systemic scleroderma	0.00018	0.000548	CcSEcCtD
Nicardipine—Body temperature increased—Methotrexate—systemic scleroderma	0.00018	0.000548	CcSEcCtD
Nicardipine—Vomiting—Prednisone—systemic scleroderma	0.000173	0.000527	CcSEcCtD
Nicardipine—Rash—Prednisone—systemic scleroderma	0.000172	0.000523	CcSEcCtD
Nicardipine—Dermatitis—Prednisone—systemic scleroderma	0.000171	0.000522	CcSEcCtD
Nicardipine—Headache—Prednisone—systemic scleroderma	0.00017	0.000519	CcSEcCtD
Nicardipine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000167	0.00051	CcSEcCtD
Nicardipine—Asthenia—Methotrexate—systemic scleroderma	0.000163	0.000497	CcSEcCtD
Nicardipine—Nausea—Prednisone—systemic scleroderma	0.000162	0.000492	CcSEcCtD
Nicardipine—Diarrhoea—Methotrexate—systemic scleroderma	0.000156	0.000474	CcSEcCtD
Nicardipine—Dizziness—Methotrexate—systemic scleroderma	0.00015	0.000458	CcSEcCtD
Nicardipine—Vomiting—Methotrexate—systemic scleroderma	0.000145	0.00044	CcSEcCtD
Nicardipine—Rash—Methotrexate—systemic scleroderma	0.000143	0.000437	CcSEcCtD
Nicardipine—Dermatitis—Methotrexate—systemic scleroderma	0.000143	0.000436	CcSEcCtD
Nicardipine—Headache—Methotrexate—systemic scleroderma	0.000142	0.000434	CcSEcCtD
Nicardipine—Nausea—Methotrexate—systemic scleroderma	0.000135	0.000411	CcSEcCtD
Nicardipine—CHRM2—Signaling Pathways—SMAD7—systemic scleroderma	3.53e-05	0.000649	CbGpPWpGaD
Nicardipine—ADRA1B—GPCR ligand binding—CCL2—systemic scleroderma	3.53e-05	0.000649	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—SMAD7—systemic scleroderma	3.52e-05	0.000648	CbGpPWpGaD
Nicardipine—ADRA1D—GPCR downstream signaling—EDN1—systemic scleroderma	3.52e-05	0.000647	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—HSPG2—systemic scleroderma	3.48e-05	0.000641	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	3.44e-05	0.000633	CbGpPWpGaD
Nicardipine—PDE1B—Signaling by GPCR—CCL2—systemic scleroderma	3.44e-05	0.000633	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—EDN1—systemic scleroderma	3.4e-05	0.000625	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—CSK—systemic scleroderma	3.36e-05	0.000619	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CSK—systemic scleroderma	3.25e-05	0.000598	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—EDN1—systemic scleroderma	3.25e-05	0.000598	CbGpPWpGaD
Nicardipine—CACNA1C—Developmental Biology—TGFB1—systemic scleroderma	3.24e-05	0.000596	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IRF5—systemic scleroderma	3.2e-05	0.000589	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—EDN1—systemic scleroderma	3.19e-05	0.000587	CbGpPWpGaD
Nicardipine—CHRM1—GPCR ligand binding—CCL2—systemic scleroderma	3.19e-05	0.000586	CbGpPWpGaD
Nicardipine—CHRM3—GPCR ligand binding—CCL2—systemic scleroderma	3.18e-05	0.000584	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—HLA-DQB1—systemic scleroderma	3.15e-05	0.000579	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CSK—systemic scleroderma	3.15e-05	0.000579	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CSK—systemic scleroderma	3.15e-05	0.000579	CbGpPWpGaD
Nicardipine—CHRM2—GPCR ligand binding—CCL2—systemic scleroderma	3.14e-05	0.000578	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	3.14e-05	0.000577	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR ligand binding—CCL2—systemic scleroderma	3.14e-05	0.000577	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—HSPG2—systemic scleroderma	3.11e-05	0.000572	CbGpPWpGaD
Nicardipine—CALM3—Disease—HSPG2—systemic scleroderma	3.11e-05	0.000572	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IRF5—systemic scleroderma	3.1e-05	0.000569	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IRF5—systemic scleroderma	3.1e-05	0.000569	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—RHOB—systemic scleroderma	3.07e-05	0.000564	CbGpPWpGaD
Nicardipine—CALM3—Immune System—ITGAM—systemic scleroderma	3.06e-05	0.000563	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CD247—systemic scleroderma	3.06e-05	0.000563	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IRF8—systemic scleroderma	3.06e-05	0.000563	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—HLA-DQB1—systemic scleroderma	3.04e-05	0.00056	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—HLA-DQB1—systemic scleroderma	3.04e-05	0.00056	CbGpPWpGaD
Nicardipine—CALM2—Disease—HSPG2—systemic scleroderma	3.01e-05	0.000553	CbGpPWpGaD
Nicardipine—CALM1—Disease—HSPG2—systemic scleroderma	3.01e-05	0.000553	CbGpPWpGaD
Nicardipine—CALM3—Disease—CSK—systemic scleroderma	3e-05	0.000552	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SMAD7—systemic scleroderma	2.98e-05	0.000549	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—EDN1—systemic scleroderma	2.97e-05	0.000547	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—CD40LG—systemic scleroderma	2.97e-05	0.000547	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CD247—systemic scleroderma	2.96e-05	0.000544	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IRF8—systemic scleroderma	2.96e-05	0.000544	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CD247—systemic scleroderma	2.96e-05	0.000544	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IRF8—systemic scleroderma	2.96e-05	0.000544	CbGpPWpGaD
Nicardipine—CALM1—Immune System—ITGAM—systemic scleroderma	2.96e-05	0.000544	CbGpPWpGaD
Nicardipine—CALM2—Immune System—ITGAM—systemic scleroderma	2.96e-05	0.000544	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—MMP1—systemic scleroderma	2.92e-05	0.000538	CbGpPWpGaD
Nicardipine—ADRA1B—GPCR downstream signaling—EDN1—systemic scleroderma	2.92e-05	0.000537	CbGpPWpGaD
Nicardipine—CALM1—Disease—CSK—systemic scleroderma	2.9e-05	0.000534	CbGpPWpGaD
Nicardipine—CALM2—Disease—CSK—systemic scleroderma	2.9e-05	0.000534	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—HSPG2—systemic scleroderma	2.89e-05	0.000532	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SMAD7—systemic scleroderma	2.89e-05	0.000531	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SMAD7—systemic scleroderma	2.89e-05	0.000531	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—CD40LG—systemic scleroderma	2.87e-05	0.000529	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—CD40LG—systemic scleroderma	2.87e-05	0.000529	CbGpPWpGaD
Nicardipine—CALM3—Immune System—TNFAIP3—systemic scleroderma	2.86e-05	0.000527	CbGpPWpGaD
Nicardipine—CALM3—Immune System—BLK—systemic scleroderma	2.83e-05	0.000521	CbGpPWpGaD
Nicardipine—PDE1A—Disease—NOS3—systemic scleroderma	2.83e-05	0.00052	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—MMP1—systemic scleroderma	2.83e-05	0.00052	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—MMP1—systemic scleroderma	2.83e-05	0.00052	CbGpPWpGaD
Nicardipine—CALM3—Disease—CD247—systemic scleroderma	2.82e-05	0.000519	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CSK—systemic scleroderma	2.79e-05	0.000514	CbGpPWpGaD
Nicardipine—CALM2—Immune System—TNFAIP3—systemic scleroderma	2.77e-05	0.00051	CbGpPWpGaD
Nicardipine—CALM1—Immune System—TNFAIP3—systemic scleroderma	2.77e-05	0.00051	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—RHOB—systemic scleroderma	2.77e-05	0.000509	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—RHOB—systemic scleroderma	2.76e-05	0.000507	CbGpPWpGaD
Nicardipine—CALM1—Immune System—BLK—systemic scleroderma	2.74e-05	0.000504	CbGpPWpGaD
Nicardipine—CALM2—Immune System—BLK—systemic scleroderma	2.74e-05	0.000504	CbGpPWpGaD
Nicardipine—CALM2—Disease—CD247—systemic scleroderma	2.73e-05	0.000502	CbGpPWpGaD
Nicardipine—CALM1—Disease—CD247—systemic scleroderma	2.73e-05	0.000502	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—RHOB—systemic scleroderma	2.73e-05	0.000502	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—RHOB—systemic scleroderma	2.72e-05	0.000501	CbGpPWpGaD
Nicardipine—CALM3—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	2.72e-05	0.0005	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—HSPG2—systemic scleroderma	2.68e-05	0.000492	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—EDN1—systemic scleroderma	2.65e-05	0.000488	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—EDN1—systemic scleroderma	2.63e-05	0.000484	CbGpPWpGaD
Nicardipine—CALM2—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	2.63e-05	0.000484	CbGpPWpGaD
Nicardipine—CALM1—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	2.63e-05	0.000484	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—EDN1—systemic scleroderma	2.62e-05	0.000483	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—HSPG2—systemic scleroderma	2.62e-05	0.000482	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—HSPG2—systemic scleroderma	2.62e-05	0.000481	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—HSPG2—systemic scleroderma	2.61e-05	0.00048	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—IL1B—systemic scleroderma	2.61e-05	0.00048	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—HSPG2—systemic scleroderma	2.6e-05	0.000479	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—HSPG2—systemic scleroderma	2.6e-05	0.000478	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—EDN1—systemic scleroderma	2.6e-05	0.000478	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—EDN1—systemic scleroderma	2.59e-05	0.000477	CbGpPWpGaD
Nicardipine—PDE1B—Disease—NOS3—systemic scleroderma	2.59e-05	0.000476	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—HSPG2—systemic scleroderma	2.58e-05	0.000474	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—HSPG2—systemic scleroderma	2.57e-05	0.000472	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CSK—systemic scleroderma	2.52e-05	0.000464	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—HSPG2—systemic scleroderma	2.52e-05	0.000463	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—HSPG2—systemic scleroderma	2.52e-05	0.000463	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CSK—systemic scleroderma	2.51e-05	0.000462	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CSK—systemic scleroderma	2.49e-05	0.000458	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CSK—systemic scleroderma	2.48e-05	0.000456	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—CCL2—systemic scleroderma	2.42e-05	0.000446	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—EDN1—systemic scleroderma	2.39e-05	0.00044	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—IL1B—systemic scleroderma	2.38e-05	0.000439	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—EDN1—systemic scleroderma	2.38e-05	0.000438	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—EDN1—systemic scleroderma	2.36e-05	0.000434	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—CTGF—systemic scleroderma	2.36e-05	0.000434	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—EDN1—systemic scleroderma	2.35e-05	0.000433	CbGpPWpGaD
Nicardipine—CACNB2—Metabolism—NOS3—systemic scleroderma	2.34e-05	0.000431	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—CCL2—systemic scleroderma	2.32e-05	0.000427	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CTLA4—systemic scleroderma	2.32e-05	0.000426	CbGpPWpGaD
Nicardipine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	2.31e-05	0.000426	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—RHOB—systemic scleroderma	2.31e-05	0.000425	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—HSPG2—systemic scleroderma	2.27e-05	0.000417	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CTLA4—systemic scleroderma	2.24e-05	0.000412	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CTLA4—systemic scleroderma	2.24e-05	0.000412	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—RHOB—systemic scleroderma	2.23e-05	0.000411	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—RHOB—systemic scleroderma	2.23e-05	0.000411	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—CCL2—systemic scleroderma	2.22e-05	0.000409	CbGpPWpGaD
Nicardipine—CACNA1D—Metabolism—NOS3—systemic scleroderma	2.22e-05	0.000408	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—CCL2—systemic scleroderma	2.18e-05	0.000402	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HSPG2—systemic scleroderma	2.18e-05	0.000401	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—NOS3—systemic scleroderma	2.12e-05	0.00039	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HSPG2—systemic scleroderma	2.11e-05	0.000387	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—HSPG2—systemic scleroderma	2.11e-05	0.000387	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CSK—systemic scleroderma	2.1e-05	0.000387	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—EDN1—systemic scleroderma	2.09e-05	0.000385	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—NOS3—systemic scleroderma	2.05e-05	0.000377	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—NOS3—systemic scleroderma	2.05e-05	0.000377	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CSK—systemic scleroderma	2.03e-05	0.000374	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CSK—systemic scleroderma	2.03e-05	0.000374	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—CCL2—systemic scleroderma	2.03e-05	0.000374	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—CTGF—systemic scleroderma	2.03e-05	0.000373	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—HSPG2—systemic scleroderma	2.02e-05	0.000372	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—EDN1—systemic scleroderma	2.01e-05	0.000369	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—EDN1—systemic scleroderma	2e-05	0.000367	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—CTGF—systemic scleroderma	1.99e-05	0.000365	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—CTGF—systemic scleroderma	1.98e-05	0.000365	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—NOS3—systemic scleroderma	1.98e-05	0.000364	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—HSPG2—systemic scleroderma	1.97e-05	0.000363	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—CTGF—systemic scleroderma	1.97e-05	0.000363	CbGpPWpGaD
Nicardipine—CACNA1C—Metabolism—NOS3—systemic scleroderma	1.95e-05	0.000359	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—EDN1—systemic scleroderma	1.93e-05	0.000355	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—EDN1—systemic scleroderma	1.93e-05	0.000355	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—CTGF—systemic scleroderma	1.91e-05	0.000351	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—CTGF—systemic scleroderma	1.91e-05	0.000351	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HLA-DQB1—systemic scleroderma	1.91e-05	0.000351	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—EDN1—systemic scleroderma	1.89e-05	0.000347	CbGpPWpGaD
Nicardipine—PDE1A—Disease—TGFB1—systemic scleroderma	1.87e-05	0.000344	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—HSPG2—systemic scleroderma	1.86e-05	0.000342	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HLA-DQB1—systemic scleroderma	1.85e-05	0.00034	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HLA-DQB1—systemic scleroderma	1.85e-05	0.00034	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—HSPG2—systemic scleroderma	1.84e-05	0.000339	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL1A—systemic scleroderma	1.81e-05	0.000333	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—NOS3—systemic scleroderma	1.81e-05	0.000333	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—CCL2—systemic scleroderma	1.81e-05	0.000333	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CD40LG—systemic scleroderma	1.8e-05	0.000332	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL1A—systemic scleroderma	1.75e-05	0.000323	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL1A—systemic scleroderma	1.75e-05	0.000323	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CD40LG—systemic scleroderma	1.74e-05	0.000321	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CD40LG—systemic scleroderma	1.74e-05	0.000321	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—CTGF—systemic scleroderma	1.72e-05	0.000316	CbGpPWpGaD
Nicardipine—PDE1B—Disease—TGFB1—systemic scleroderma	1.71e-05	0.000315	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—CCL2—systemic scleroderma	1.63e-05	0.000301	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—CCL2—systemic scleroderma	1.63e-05	0.0003	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—CCL2—systemic scleroderma	1.61e-05	0.000297	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—CCL2—systemic scleroderma	1.61e-05	0.000296	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—MMP9—systemic scleroderma	1.59e-05	0.000292	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EDN1—systemic scleroderma	1.57e-05	0.000288	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—CTGF—systemic scleroderma	1.53e-05	0.000282	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—CTGF—systemic scleroderma	1.5e-05	0.000275	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—MMP9—systemic scleroderma	1.45e-05	0.000267	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—CCL2—systemic scleroderma	1.43e-05	0.000263	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EDN1—systemic scleroderma	1.41e-05	0.00026	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—CTGF—systemic scleroderma	1.41e-05	0.000259	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EDN1—systemic scleroderma	1.41e-05	0.000259	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—TGFB1—systemic scleroderma	1.4e-05	0.000258	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—CTGF—systemic scleroderma	1.4e-05	0.000257	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EDN1—systemic scleroderma	1.39e-05	0.000257	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EDN1—systemic scleroderma	1.39e-05	0.000256	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—CCL2—systemic scleroderma	1.37e-05	0.000252	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—CCL2—systemic scleroderma	1.36e-05	0.000251	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—TGFB1—systemic scleroderma	1.36e-05	0.000249	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—TGFB1—systemic scleroderma	1.36e-05	0.000249	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—CCL2—systemic scleroderma	1.32e-05	0.000243	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—CCL2—systemic scleroderma	1.32e-05	0.000243	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—TGFB1—systemic scleroderma	1.31e-05	0.000241	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—CCL2—systemic scleroderma	1.29e-05	0.000237	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—NOS3—systemic scleroderma	1.28e-05	0.000235	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—NOS3—systemic scleroderma	1.22e-05	0.000225	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—HSPG2—systemic scleroderma	1.22e-05	0.000224	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—TGFB1—systemic scleroderma	1.2e-05	0.00022	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EDN1—systemic scleroderma	1.18e-05	0.000217	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—NOS3—systemic scleroderma	1.15e-05	0.000211	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EDN1—systemic scleroderma	1.14e-05	0.00021	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EDN1—systemic scleroderma	1.14e-05	0.00021	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CCL2—systemic scleroderma	1.07e-05	0.000197	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—NOS3—systemic scleroderma	1.03e-05	0.000189	CbGpPWpGaD
Nicardipine—CALM3—Disease—NOS3—systemic scleroderma	1.03e-05	0.000189	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—MMP9—systemic scleroderma	1.02e-05	0.000188	CbGpPWpGaD
Nicardipine—CALM2—Disease—NOS3—systemic scleroderma	9.92e-06	0.000183	CbGpPWpGaD
Nicardipine—CALM1—Disease—NOS3—systemic scleroderma	9.92e-06	0.000183	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—MMP9—systemic scleroderma	9.81e-06	0.00018	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CCL2—systemic scleroderma	9.66e-06	0.000178	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CCL2—systemic scleroderma	9.63e-06	0.000177	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—NOS3—systemic scleroderma	9.54e-06	0.000175	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CCL2—systemic scleroderma	9.53e-06	0.000175	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CCL2—systemic scleroderma	9.51e-06	0.000175	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL1B—systemic scleroderma	9.45e-06	0.000174	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MMP9—systemic scleroderma	9.22e-06	0.00017	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CTGF—systemic scleroderma	9.21e-06	0.00017	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL1B—systemic scleroderma	9.14e-06	0.000168	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL1B—systemic scleroderma	9.14e-06	0.000168	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—NOS3—systemic scleroderma	8.83e-06	0.000162	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—NOS3—systemic scleroderma	8.65e-06	0.000159	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—NOS3—systemic scleroderma	8.63e-06	0.000159	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—NOS3—systemic scleroderma	8.61e-06	0.000158	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—NOS3—systemic scleroderma	8.59e-06	0.000158	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—NOS3—systemic scleroderma	8.58e-06	0.000158	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—NOS3—systemic scleroderma	8.5e-06	0.000156	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—NOS3—systemic scleroderma	8.47e-06	0.000156	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TGFB1—systemic scleroderma	8.44e-06	0.000155	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—NOS3—systemic scleroderma	8.31e-06	0.000153	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—NOS3—systemic scleroderma	8.31e-06	0.000153	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TGFB1—systemic scleroderma	8.08e-06	0.000149	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCL2—systemic scleroderma	8.06e-06	0.000148	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCL2—systemic scleroderma	7.8e-06	0.000143	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCL2—systemic scleroderma	7.8e-06	0.000143	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MMP9—systemic scleroderma	7.65e-06	0.000141	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TGFB1—systemic scleroderma	7.6e-06	0.00014	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—NOS3—systemic scleroderma	7.47e-06	0.000137	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NOS3—systemic scleroderma	7.18e-06	0.000132	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NOS3—systemic scleroderma	6.95e-06	0.000128	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NOS3—systemic scleroderma	6.95e-06	0.000128	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MMP9—systemic scleroderma	6.91e-06	0.000127	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MMP9—systemic scleroderma	6.88e-06	0.000127	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MMP9—systemic scleroderma	6.82e-06	0.000125	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MMP9—systemic scleroderma	6.8e-06	0.000125	CbGpPWpGaD
Nicardipine—CALM3—Disease—TGFB1—systemic scleroderma	6.78e-06	0.000125	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—NOS3—systemic scleroderma	6.67e-06	0.000123	CbGpPWpGaD
Nicardipine—CALM2—Disease—TGFB1—systemic scleroderma	6.56e-06	0.000121	CbGpPWpGaD
Nicardipine—CALM1—Disease—TGFB1—systemic scleroderma	6.56e-06	0.000121	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—NOS3—systemic scleroderma	6.51e-06	0.00012	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TGFB1—systemic scleroderma	6.31e-06	0.000116	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—NOS3—systemic scleroderma	6.13e-06	0.000113	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—NOS3—systemic scleroderma	6.08e-06	0.000112	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MMP9—systemic scleroderma	5.76e-06	0.000106	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TGFB1—systemic scleroderma	5.69e-06	0.000105	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TGFB1—systemic scleroderma	5.67e-06	0.000104	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TGFB1—systemic scleroderma	5.62e-06	0.000103	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TGFB1—systemic scleroderma	5.6e-06	0.000103	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MMP9—systemic scleroderma	5.57e-06	0.000103	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MMP9—systemic scleroderma	5.57e-06	0.000103	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TGFB1—systemic scleroderma	4.75e-06	8.74e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TGFB1—systemic scleroderma	4.59e-06	8.45e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TGFB1—systemic scleroderma	4.59e-06	8.45e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—NOS3—systemic scleroderma	4.01e-06	7.38e-05	CbGpPWpGaD
